Discover
SUDOSCAN®
Our objective is to offer screening tests to the medical community to address the rapidly spreading metabolic disorders and their associated complications.
Our History
SUDOSCAN® Device -The patented technology behind the SUDOSCAN® device is designed to assess sudomotor function by evaluating sweat gland activity. The procedure is non-invasive and works by measuring the release of chloride ions from sweat glands in response to an electrical stimulus. Conductance measurements are taken on the palms of the hands and the soles of the feet, which are linked to the status of small nerve fibers that innervate sweat glands. Small fiber neuropathy is common in the early stages of diabetes and prediabetes. SUDOSCAN® has developed a proven proprietary technology that enables the early detection of neuropathies caused by diabetes complications, even when the condition is still reversible. The technology also allows for easy and quantifiable monitoring of a patient's neuropathic complications over time.
Company Mission
Our mission is to offer innovative and distinctive medical devices to enhance the management and treatment of diabetes and conditions resulting in neuropathies. We strive to provide patients and healthcare professionals with novel tools that aid in improving disease management and overall quality of life.
Advancing Healthcare Through Clinical Research
In the realm of modern healthcare, the pursuit of accurate and efficient diagnostic tools is paramount. Enter SUDOSCAN, a pioneering medical device that has garnered widespread attention for its transformative role in neuropathy assessment. This article delves into the world of SUDOSCAN clinical research studies, shedding light on the profound impact it has made as a diagnostic tool for physicians worldwide.
A Beacon of Innovation: SUDOSCAN's Foundation
Central to SUDOSCAN's journey are its multiple patents and coveted FDA clearance, solidifying its status as a credible and reliable diagnostic tool. These distinctions are not merely badges of honor but a testament to the relentless pursuit of excellence that underpins SUDOSCAN's design.
Clinical Research: Illuminating SUDOSCAN's Efficacy
The efficacy of any medical device is underpinned by robust clinical research, and SUDOSCAN is no exception. Rigorous studies have been conducted, unraveling the potential of SUDOSCAN as a powerful diagnostic ally for physicians. Through meticulous trials and investigations, SUDOSCAN's ability to assess sudomotor function – a pivotal indicator of autonomic nervous system health – has been showcased, opening new avenues for neuropathy detection and management.
The Global Impact: Empowering Physicians Worldwide
The impact of SUDOSCAN transcends geographical boundaries. Physicians around the world have embraced this innovative tool, recognizing its potential to revolutionize patient care. By offering quick, non-invasive, and objective assessments, SUDOSCAN equips physicians with a diagnostic edge that transforms the patient journey. From early detection of neuropathy to monitoring disease progression, SUDOSCAN's versatility has redefined how physicians approach neuropathic conditions.
A Journey of Transformation: Redefining Neuropathy Diagnosis
The journey of SUDOSCAN is a journey of transformation. It signifies the fusion of cutting-edge technology, clinical research, and unwavering dedication to enhancing patient outcomes. As SUDOSCAN paves the way for more accurate, efficient, and accessible neuropathy assessment, its impact reverberates through healthcare practices, inspiring a new era of diagnostic excellence.
SUDOSCAN: A Beacon of Progress
In an ever-evolving healthcare landscape, SUDOSCAN stands as a beacon of progress. Its clinical research studies, which can be explored in-depth on our blog, offer a glimpse into its transformative potential. As we celebrate SUDOSCAN's multiple patents and FDA clearance, we invite you to embark on a journey of discovery – one that unveils the remarkable strides this diagnostic tool has made and continues to make in the world of healthcare.